TWA1 inhibitors are a class of chemical compounds that specifically target and inhibit the function of the TWA1 protein, which is part of the TREX-2 (Transcription-Export 2) complex. TWA1 plays a key role in mRNA export from the nucleus to the cytoplasm, ensuring that newly transcribed mRNA is efficiently transported out of the nucleus for translation. This process is critical for maintaining proper gene expression and protein synthesis within the cell. TWA1 is involved in linking mRNA export machinery to nuclear pore complexes, which are gateways that regulate the passage of molecules between the nucleus and cytoplasm. Inhibiting TWA1 disrupts this process, leading to potential alterations in gene expression and cellular function.
The structural design of TWA1 inhibitors typically focuses on blocking regions of the protein that interact with other components of the TREX-2 complex or with nuclear pore complexes. These inhibitors may bind to critical domains of TWA1, preventing its association with mRNA export machinery or disrupting its role in stabilizing the connection between mRNA and the nuclear pores. By inhibiting TWA1, researchers can study the precise role this protein plays in mRNA trafficking and how its disruption impacts the cellular processes dependent on effective mRNA export. This inhibition provides a valuable tool for exploring the molecular mechanisms of nuclear-cytoplasmic transport, RNA processing, and the broader regulation of gene expression within cells. Through the use of TWA1 inhibitors, insights can be gained into how cells maintain the balance of mRNA export and the coordination of transcription and translation.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
Triptolide may inhibit transcription factors involved in the expression of GID8, leading to decreased GID8 mRNA synthesis. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D intercalates into DNA, potentially preventing transcription of the GID8 gene. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Sirolimus inhibits mTOR, which may downregulate protein synthesis including that of GID8. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine may cause DNA hypomethylation, potentially disrupting the expression regulation of GID8. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide blocks peptide elongation during protein synthesis, which could reduce GID8 protein levels. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
Alpha-amanitin inhibits RNA polymerase II, potentially decreasing GID8 mRNA transcription. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG132 inhibits proteasomes, potentially inducing a general stress response that downregulates GID8 expression indirectly. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine can raise endosomal pH, which might interfere with the trafficking and function of proteins, including GID8. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Bortezomib inhibits the proteasome, potentially altering cellular protein homeostasis and indirectly affecting GID8 levels. | ||||||
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $39.00 $59.00 $104.00 $206.00 | 8 | |
Geldanamycin binds to Hsp90, potentially destabilizing client proteins and affecting GID8 protein folding or stability. | ||||||